StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
057680.KQ$2310.00-5.52%
Fair $2310.00+0.0%

057680.KQ

T Scientific Co.,Ltd.

Unknown / UnknownKOSDAQ

$2310.00

-135.00 (-5.52%)

Fairly Valued+0.0%Fair Value $2310.00Fund rank 27/100 · Data gapFallback financials|
SA 20/D
F-Score: 4/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 21%

FCF escenarios

weak_data · normalized FCF $-11.4B · quality 58.3/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 22/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

20/100

D

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -0.8%, below the 5% threshold
Thesis & Journal · 057680.KQLocal privado en este navegador · T Scientific Co.,Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$32.9B

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-0.8%

↓

Gross Margin

30.4%

↑

Debt/Equity

0.04

↓
52-Week Range$2310
$2190$8245

TradingView lightweight chart

057680.KQ price, volumen y niveles de valoración

Último $2,310Periodo -92.4%
Fair value: $2,310

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+61.1%

FCF CAGR

—

FCF margin

1.7%

FCF / Net income

-0.49x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $36.37B · net income $-1.28B · FCF $622.4M

2022-FY → 2025-FY

Gross margin

30.4%-17.7% pts

Operating margin

0.7%+29.3% pts

Net margin

-3.5%+124.3% pts

FCF margin

1.7%+32.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$36.37B$36.37B$43.02B$26.77B$8.69B
Net Income$-1.28B$-1.28B$2.22B$-45.41B$-11.11B
EBITDA$-3.05B$-3.05B$3.52B$-50.21B$-12.53B
EPS-90.00-90.00160.00-3685.00-1050.00
Gross Margin30.4%30.4%23.1%30.3%48.2%
Operating Margin0.7%0.7%-18.3%-21.0%-28.6%
Net Margin-3.5%-3.5%5.2%-169.7%-127.8%
Balance Sheet
Debt/Equity0.040.040.050.100.21
Cash Flow
Free Cash Flow$622.4M$622.4M$-13.28B$-11.43B$-2.69B
Returns
ROE-0.8%-0.8%1.6%-34.6%-6.2%
Valuation
P/E——32.19——
EV/EBITDA——21.35——
P/B0.190.190.510.780.72
Growth & Yield
Revenue Growth-15.5%-15.5%60.7%207.9%—
EPS Growth-156.3%-156.3%104.3%-251.0%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -45.6%

Total return

-45.6%

Start / end P/E

n/dx → n/dx

EPS bridge

160.00 → -90.00

Residual

-45.6%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-45.6%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.